Cravens & Co Advisors, LLC
- SEC CIK
- 0001966116
- Latest filing
- Aug 12, 2026
REGN holding history
Regeneron Pharmaceuticals, Inc. in every 13F filed by Cravens & Co Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
REGN overviewAll 13F holders of REGNFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −1,286−100.0% | Sold out | Holders |
| Q1 2025 | 1,286 | $815.6K | 0.6% | +123+10.6% | Added | Holders |
| Q4 2024 | 1,163 | $828.4K | 0.6% | −142−10.9% | Reduced | Holders |
| Q3 2024 | 1,305 | $1.37M | 1.1% | +71+5.8% | Added | Holders |
| Q2 2024 | 1,234 | $1.30M | 1.0% | −57−4.4% | Reduced | Holders |
| Q1 2024 | 1,291 | $1.24M | 1.0% | +7+0.5% | Added | Holders |
| Q4 2023 | 1,284 | $1.13M | 1.0% | −16−1.2% | Reduced | Holders |
| Q3 2023 | 1,300 | $1.07M | 1.0% | +71+5.8% | Added | Holders |
| Q2 2023 | 1,229 | $883.1K | 0.8% | −10−0.8% | Reduced | Holders |
| Q1 2023 | 1,239 | $1.02M | 1.0% | −8−0.6% | Reduced | Holders |
| Q4 2022 | 1,247 | $899.7K | 0.8% | – | No prior filing | Holders |